definiens: means all Patents [COMPANY] Controls during the term o f this Agreement that claim or Cover [COMPANY] Platform Technology . ( Fo r clarity, [COMPANY] Platform Patents exclude Program Antibody Patents . ) 1.6 means all Know - How Controlled by [COMPANY] ( including via assignment from iTeos under this Agreement ) and its Affiliates and [COMPANY] Platform Patents regarding ( a ) the discovery and optimization of antibodies via method s that include the use of synthetic DNA antibody li braries and engineered strains of yeast and interrogating r epertoires generated through B - cell cloning, ( b ) al l methods, materials and other Know - How used in the foregoing and ( c ) platforms embodying, components, component steps and other portions of any of the foregoing in ( a ) or ( b ) . For clarity, [COMPANY] Platform Technolog y excludes Program Antibodies but includes technology used in the discovery and optimization of any Program Antib ody, in each case not based on the specific composition of such Program Antibody ( or product containing a P rogram Antibody ), but based instead on the manner in which such Program Antibody was discovered or optimized under a Research Program